SMTL ID : 7rrc.1 (1 other biounit)

IDO1 IN COMPLEX WITH COMPOUND 14

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.18 Å

Oligo State

monomer

Ligands

1 x 6RI: N-(4-fluorophenyl)-3-{4-[4-(hydroxymethyl)-6-(trifluoromethyl)pyridin-3-yl]phenyl}oxetane-3-carboxamide(Non-covalent)

6RI.1: 19 residues within 4Å: Chain A: Y.117, C.120, V.121, F.154, S.158, V.161, E.162, F.205, I.208, G.253, S.254, A.255, S.258, V.260, F.261, L.330, L.333, R.334, H.337 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.121, A:F.154, A:F.205, A:F.205, A:A.255, A:V.260 Hydrogen bonds: A:Y.117, A:S.158, A:S.158, A:E.162, A:E.162, A:S.258 Water bridges: A:A.255 pi-Stacking: A:Y.117, A:H.337

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, D. et al., Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing. J.Med.Chem. (2022)

Release Date

2022-03-16

Peptides

Indoleamine 2,3-dioxygenase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence